Skip to content
Company Analysis

Sharps Technology Inc. Warrant STSSW

A comprehensive view of key metrics, scores, and financial health for Sharps Technology Inc. Warrant

Overview of Sharps Technology, Inc.

STSSW NCM
Healthcare Medical Instruments & Supplies Framework: Medical Devices & Diagnostics
Sharps Technology, Inc. (STSSW), in the Medical Instruments & Supplies industry, last closed at $0.03, about 0.0% overvalued vs fair value, ranked 1112/1145 in sector.
Metrics ROE -212.1% Gross Margin -202.5%
USD 0.03
0.00%
(Delayed)
• Vol 90d: 83.6%
52-Week Range
Enterprise Value
-
Overall Score
View breakdown
Overall
Growth
Fair
Profitability
Weak
Health
Weak
Efficiency
Weak
Growth
Fair
Profitability
Weak
Health
Weak
Efficiency
Weak
Completeness: 56%
Confidence: 68%
Updated: Jul 5
Top Beats
No strong beats yet

Quick Facts

Website https://sharpstechnology.com
HQ Melville, NY
Employees 55
Fiscal year Dec 31

Next Events

No upcoming events available.

Fair Value Snapshot

Insufficient data
Show more details
  • Shares outstanding missing or non-positive

Engine Room Money Flow™

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$204.1K
Gross Profit
$-413.3K
Operating Income (GAAP)
$-13.3M
-138.7%%
EBITDA
$-269.8M
-7557.8%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
-202.5%
Poor

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
2
Active Leaks
0/2
Improving
0
High Impact
2
Critical
Locked Leak
Upgrade to view details
Premium
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating Sharps Technology Inc. Warrant's durable competitive advantages across 6 defense dimensions

Overall Moat Strength
19
/100
Weak
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Weak
3
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 60% Coverage
Trade-Off Triangle Visualization A ternary plot showing STSSW's balance between Growth (33.3%), Profitability (13.9%), and Safety (52.8%). Growth 33% Safety 53% Profitability 14%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

- vs peers
-
Key Signals
Asset Growth YoY 35.79 99p
Strengths
  • D/E Ratio in top 20% of peers (1.2%, 83th percentile)
  • Equity/Assets in top 20% of peers (98.3%, 98th percentile)
  • Debt/Assets in top 20% of peers (1.1%, 93th percentile)
  • Conservative leverage compared to industry peers
Risks

No significant risks identified for this axis.

Profitability

13th percentile vs peers
14
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

52th percentile vs peers
53
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Sharps Technology Inc. Warrant.

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
-
- - -
- upside
-
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000